Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Andrea Ardizzoni | Researchclopedia

Back to researchers

Andrea Ardizzoni

Policlinico S.Orsola-Malpighi ORCID

794

Works

20,269

Citations

69

h-index

319

i10-index

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers

Affiliations

University of Foggia2014–2014

University of Insubria2014–2014

University of Verona2015–2015

Marche Polytechnic University2005–2005

University of Parma2004–2016

Top Works

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ <i>neu</i> –Positive Metastatic Breast Cancer

Antonino Musolino,Nadia Naldi,et al.

2008950 citations

Colorectal Cancer Treatments and Studies

Lung Cancer Diagnosis and Treatment

Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

Andrea Ardizzoni,Luca Boni,et al.

2007605 citations

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Kazuhiko Nakagawa,Edward B. Garon,et al.

2019602 citations

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

Anne‐Marie C. Dingemans,Martin Früh,et al.

2021545 citations

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

Andrea Ardizzoni,H. Hansen,et al.

1997481 citations

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

Jean‐Charles Soria,Enriqueta Felip,et al.

2015432 citations

Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer

U. Gatzemeier,G. Groth,et al.

2003384 citations

Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer

John R. Eckardt,Joachim von Pawel,et al.

2007380 citations

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

Rafael Rosell,U. Gatzemeier,et al.

2002299 citations